November 1, 2007 - Siemens said today it is acquiring U.S.-based laboratory diagnostics company Dade Behring and hopes to close the transaction by Nov. 6.
Siemens is purchasing about 94 percent of the outstanding common stock of Dade Behring. After closing, Siemens officials said Dade Behring will be integrated in the existing business of Siemens Medical Solutions Diagnostics, a wholly owned subsidiary of Siemens Medical Solutions USA Inc.
“Becoming the leader in the laboratory diagnostics market enables Siemens to offer its customers a comprehensive portfolio of innovative solutions across the whole healthcare continuum - from prevention to diagnosis, to therapy and care,” said Erich R. Reinhardt, member of the Managing Board of Siemens AG and president and CEO of Siemens Medical Solutions (Med). “There is no other company that can bring together the entire medical imaging, laboratory diagnostics and clinical IT value chain under one roof. Siemens alone can offer opportunities for the integration of such a comprehensive range of technology, workflows and information that will help our customers deliver an improved quality of patient care at reduced costs.”
Reinhardt said Dade Behring’s strong position in the field of clinical chemistry will complement Siemens’ laboratory business.
For more information: www.siemens.com, www.dadebehring.com
May 24, 2024 
